Kuehn Law Encourages Investors of Skyworks Solutions, Inc. to Contact Law Firm

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Skyworks Solutions, Inc. (NASDAQ: SWKS) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Insiders at Skyworks caused the company to misrepresent or fail to disclose material adverse facts concerning the true state of Skyworks’ client base; notably, that its long-standing relationship with Apple, its largest customer, did not guarantee that Apple would maintain its business relationship with Skyworks for its anticipated iPhone launch. Additionally, insiders oversold Skyworks’ position and ability to capitalize on AI in the smartphone upgrade cycle.

If you currently own SWKS and purchased prior to July 30, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™  

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814



CNH announces voting results of 2026 Annual General Meeting and publishes 2025 Sustainability Report

CNH announces voting results of 2026 Annual General Meeting and publishes 2025 Sustainability Report

Basildon, May 8, 2026

CNH Industrial N.V. (NYSE: CNH) today held its 2026 Annual General Meeting (2026 AGM) of shareholders. Among the voting items, shareholders voted to re-appoint Suzanne Heywood and Gerrit Marx as executive directors; re-appoint Elizabeth Bastoni, Howard W. Buffett, Karen Linehan, Alessandro Nasi, and Vagn Sørensen as non-executive directors; and appoint Richard Palmer and Lorenzo Simonelli as non-executive directors.

Shareholders approved the Company’s 2025 financial statements prepared under IFRS. Shareholders also approved a dividend in cash of $0.10 per outstanding common share, totaling approximately $124.2 million.

The dividend will be paid on May 29, 2026, to shareholders of record on May 21, 2026. Shareholders holding CNH common shares deposited in Monte Titoli on the record date will receive the dividend in Euro at the official EUR/USD exchange rate of May 21, 2026 reported by the European Central Bank.

Details on all other proposals voted on by shareholders at the 2026 AGM are available on the Company’s website (investors.cnh.com/events-and-presentations/shareholder-meetings).

***

Concurrently with the 2026 AGM, the Company published its 2025 Sustainability Report. It includes CNH’s sustainability priorities, related strategic targets, and the main results achieved throughout 2025.

To consult the Report online, visit: www.cnh.com/-/media/CNHi/cnhicorporate/Sustainability/sustainability_reports/docs/CNH_Sustainability_2025_0605-Final.pdf


CNH Industrial

(NYSE: CNH) is a world-class equipment, technology and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Productivity, the Company provides the strategic direction, R&D capabilities, and investments that enable the success of its global and regional Brands. Globally,

Case IH

and

New Holland

supply 360° agriculture applications from machines to implements and the digital technologies that enhance them; and

CASE

and

New Holland Construction Equipment

deliver a full lineup of construction products that make the industry more productive. The Company’s regionally focused Brands include:

STEYR

, for agricultural tractors;

Raven

, a leader in digital agriculture, precision technology and the development of autonomous systems;

Hemisphere

, a leading designer and manufacturer of high-precision satellite-based positioning, and heading technologies;

Flexi-Coil

, specializing in tillage and seeding systems;

Miller

, manufacturing application equipment; and

Eurocomach,

producing a wide range of
mini and midi excavators for the construction sector, including electric solutions.

Across a history spanning over 180 years, CNH has always been a pioneer in its sectors and continues to passionately innovate and drive customer efficiency and success. As a truly global company, CNH’s 34,000+ employees form part of a diverse and inclusive workplace, focused on empowering customers to grow, and build, a better world.

For more information and the latest financial and sustainability reports visit:

cnh.com

For news from CNH and its Brands visit:

media.cnh.com

Contacts:

Media Relations

Email: [email protected]

Investor Relations

Email: [email protected]

Attachments



New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market

· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.

· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.

DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) — Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, “The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.” This comprehensive study provides a strategic analysis of the rapidly evolving obesity-drug landscape as the market transitions beyond first-generation GLP-1 therapies.

The release comes as Eli Lilly and Company’s retatrutide has emerged as a leading triple-agonist candidate, delivering results that approach bariatric-surgery-level efficacy and signaling a new phase in obesity therapeutics. PatentVest’s analysis suggests that the next stage of competition will extend beyond clinical outcomes into intellectual property positioning, delivery systems, and long-term market control.

The report highlights the structural shift underway in obesity drug development, driven by the convergence of GLP-1, GIP, and glucagon receptor targeting, as well as the growing importance of platform design, formulation, and freedom-to-operate strategies. Key findings include:

· Competitive Landscape: Insights into industry leaders including Eli Lilly and Company, Novo Nordisk, Pfizer, Roche, and Sanofi, alongside emerging players such as Hanmi Pharmaceutical, Innovent Biologics, Zealand Pharma, Septerna, Kailera Therapeutics, Metsera, Ascletis Pharma, Rani Therapeutics, Structure Therapeutics, and Viking Therapeutics, all competing to define the next generation of obesity therapeutics.

· Global Pipeline Expansion: Identification of 27 triple-agonist programs, with China accounting for a significant share of development activity, signaling a shift in global innovation dynamics and potential future licensing activity.

· Intellectual Property Dynamics: Patent analysis reveals a transition from receptor discovery to receptor-ratio engineering, formulation control, delivery systems, and method-of-use claims as key drivers of long-term competitive advantage.

· Strategic Positioning: Findings suggest that companies without visible clinical programs, including Sanofi, may hold significant latent IP positions that could influence the future structure of the market.

“Obesity drug development is entering a new phase,” said Will Rosellini, Chief IP Officer at PatentVest. “The first GLP-1 era was about proving these therapies could deliver meaningful weight loss. The next phase will be defined by who controls the intellectual property, delivery platforms, and receptor configurations that shape the market after retatrutide.”

The PatentVest Pulse report is now available for download on the PatentVest website: https://insights.patentvest.com/the-last-20.

For more information or inquiries, please contact [email protected].

The insights and analysis presented in this report are derived from PatentVest’s proprietary IP intelligence platform, which integrates patent data, clinical pipeline analysis, and strategic market mapping to identify emerging trends and competitive positioning across biotechnology sectors.


About PatentVest

PatentVest is the first integrated IP intelligence, strategy, and law firm built for companies where patents drive enterprise value. The firm pairs seasoned IP counsel with a dedicated analyst team and a proprietary technology platform to deliver portfolio strategy, diligence, and prosecution work with the rigor of Big Law and the speed modern innovators require. PatentVest Pulse, the firm’s research series, maps the competitive and IP landscapes of frontier technology sectors, from brain-computer interfaces and humanoid robotics to AI infrastructure and next-generation therapeutics, giving investors, boards, and operators a clear view of who owns the innovation that will define each market. PatentVest is a division of MDB Capital Holdings (Nasdaq: MDBH). Learn more at patentvest.com.



Columbia Seligman Premium Technology Growth Fund Announces a Second Quarter Distribution: 9.25% Annual Rate for IPO Investors

Columbia Seligman Premium Technology Growth Fund Announces a Second Quarter Distribution: 9.25% Annual Rate for IPO Investors

BOSTON–(BUSINESS WIRE)–
Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a second-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund’s initial public offering in November 2009. The first-quarter distribution of $0.4625 per share is equal to a quarterly rate of 0.946% (3.78% annualized) of the Fund’s market price of $48.89 per share as of April 30, 2026.

The distribution will be paid on May 26, 2026 (the Payment Date) to Stockholders of record on May 18, 2026. The ex-dividend date is May 18, 2026. It is anticipated that the Fund will make a subsequent distribution under its managed distribution policy in the month of August.

Prior to the managed distribution policy, the Fund paid distributions pursuant to a level rate distribution policy. Under its former distribution policy and consistent with the Investment Company Act of 1940, as amended, the Fund could not distribute long-term capital gains more often than once in any one taxable year.

In October 2010, the Fund received exemptive relief from the Securities and Exchange Commission that permits the Fund to make periodic distributions of long-term capital gains more often than once in any one taxable year. After consideration by the Fund’s Board, the Fund adopted the current managed distribution policy which allows the Fund to make distributions of long-term capital gains more than once in any taxable year.

The following table sets forth the estimated breakdown of the distribution noted above, on a per share basis, from the following sources: net investment income; net realized short-term capital gains; net realized long-term capital gains; and return of capital or other capital source.

 

Breakdown of Distribution

Sources

%

US Dollar

Net Investment Income

0.00%

$0.0000

Net Realized Short-Term Capital Gains

0.00%

$0.0000

Net Realized Long-Term Capital Gains

100.00%

$0.4625

Return of Capital or other Capital Source

0.00%

$0.0000

Total

100.00%

$0.4625

The following table sets forth the estimated breakdown, on a per share basis, of all distributions made by the Fund during the year-to-date period ended on the Payment Date of the above distributions (includes the distribution payment noted in the table above) from the following sources: net investment income; net realized short-term capital gains; net realized long-term capital gains; and return of capital or other capital source.

 

 

Breakdown of All Distributions Paid Through

Year-To-Date Period Ended on the Payment Date of the Current Distribution

Sources

%

US Dollar

Net Investment Income

0.00%

$0.0000

Net Realized Short-Term Capital Gains

0.00%

$0.0000

Net Realized Long-Term Capital Gains

100.00%

$0.9250

Return of Capital or other Capital Source

0.00%

$0.0000

Total

100.00%

$0.9250

In certain years since the Fund’s inception, the Fund has distributed more than its income and net realized capital gains, which has resulted in Fund distributions substantially consisting of return of capital or other capital source. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.” As of the payment date of the current distribution, all Fund distributions paid in 2026 (as estimated by the Fund based on current information) are from the earnings and profits of the Fund and not a return of capital. This could change during the remainder of the year, as further described below.

The amounts, sources and percentage breakdown of the distributions reported above are only estimates and are not being provided for, and should not be used for, tax reporting purposes. The actual amounts, sources and percentage breakdown of the distribution for tax reporting purposes, which may include return of capital, will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations.

The following table sets forth (i) the average annual total return of a share of the Fund’s common stock at net asset value (NAV) for the 5-year period ended April 30, 2026 and (ii) the Fund’s annualized distribution rate for the year-to-date period ended April 30, 2026, expressed as a percentage of the NAV price of a share of the Fund’s common stock at April 30, 2026.

 

Average Annual Total NAV Return for the 5-year Period Ended April 30, 2026

 

21.18%

Annualized Distribution Rate as a Percentage of April 30, 2026 NAV Price

(For the Year-to-Date Period ended April 30, 2026)

 

2.76%

 

The following table sets forth (i) the cumulative total return (at NAV) of a share of the Fund’s common stock for the year-to-date period ended April 30, 2026, and (ii) the Fund’s distribution rate, for the same period, expressed as a percentage of the NAV price of a share of the Fund’s common stock at April 30, 2026

Cumulative Total NAV Return for the Year-to-Date Period Ended April 30, 2026

 

34.17%

 

Distribution Rate as a Percentage of April 30, 2026, NAV Price

(For the Year-to-Date Period Ended April 30, 2026)

0.92%

You should not draw any conclusions about the Fund’s investment performance from the amount of the distributions noted in the tables above or from the terms of the Fund’s distribution policy.

The Fund or your financial professional will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions on your US federal income tax return. For tax purposes, the Fund is required to report unrealized gains or losses on certain non-US investments as ordinary income or loss, respectively. Accordingly, the amount of the Fund’s total distributions that will be taxable as ordinary income may be different than the amount of the distributions from net investment income reported above.

The Board may change the Fund’s distribution policy and the amount or timing of the distributions, based on a number of factors, including, but not limited to, the amount of the Fund’s undistributed net investment income and net short- and long-term capital gains and historical and projected net investment income and net short- and long-term capital gains.

The Fund is a closed-end investment company that trades on the New York Stock Exchange.

Past performance does not guarantee future results.

Important Disclosures:

You should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containing information about the Fund (including its investment objectives, risks, charges, expenses, and other information) may be obtained by contacting your financial advisor or the Fund’s transfer agent at 866-666-1532 or visiting columbiathreadneedleus.com. The prospectus can also be found on the Securities and Exchange Commission’s EDGAR database. The prospectus should be read carefully before investing in the Fund. There is no guarantee that the Fund’s investment goals/objectives will be met or that distributions will be made, and you could lose money.

The Fund expects to receive all or some of its current income and gains from the following sources: (i) dividends received by the Fund that are paid on the equity and equity-related securities in its portfolio; and (ii) capital gains (short-term and long-term) from option premiums and the sale of portfolio securities. It is possible that the Fund’s distributions will at times exceed the earnings and profits of the Fund and therefore all or a portion of such distributions may constitute a return of capital as described below. A return of capital is a return of your original investment. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.” You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the Fund’s distribution policy.

Distributions that qualify as a return of capital are a return of some or all of your original investment in the Fund. A return of capital reduces a stockholder’s tax basis in his or her shares. Once the tax basis in your shares has been reduced to zero, any further return of capital may be taxable as capital gain. Shareholders should consult their tax advisor or tax attorney for proper treatment.

Distributions may be variable, and the Fund’s distribution rate will depend on a number of factors, including the net earnings on the Fund’s portfolio investments and the rate at which such net earnings change as a result of changes in the timing of, and rates at which, the Fund receives income from the sources noted above. As portfolio and market conditions change, the rate of distributions on the shares and the Fund’s distribution policy could change.

Market risk may affect a single issuer, sector of the economy, industry or the market as a whole. The products of technology companies may be subject to severe competition and rapid obsolescence, and their stocks may be subject to greater price fluctuations. Investments in small- and mid-cap companies involve risks and volatility greater than investments in larger, more established companies. Foreign investments subject the fund to risks, including political, economic, market, social and others within a particular country, as well as to currency instabilities and less stringent financial and accounting standards generally applicable to U.S. issuers. As a non-diversified fund, fewer investments could have a greater effect on performance. The Fund’s derivatives strategies may not be successful and could result in significant Fund losses.

The Fund should only be considered as one element of a complete investment program. An investment in the Fund should be considered speculative. The Fund’s investment policy of investing in technology and technology-related companies and writing call options involves a high degree of risk.

There is no assurance that the Fund will meet its investment objectives or that distributions will be made. You could lose some or all of your investment. In addition, closed-end funds frequently trade at a discount to their net asset values, which may increase your risk of loss.

The Fund is not insured by the FDIC, NCUA or any federal agency, is not a deposit or obligation of, or guaranteed by any financial institution, and involves investment risks including possible loss of principal and fluctuation in value.

Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.

Columbia Seligman Premium Technology Growth Fund is managed by Columbia Management Investment Advisers, LLC.

© 2026 Columbia Threadneedle. All rights reserved.

columbiathreadneedleus.com

Adtrax: CTNA7937688.4-

Stockholder contact:

[email protected]

Media contact:

Meghan Shields

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

E-Power Granted Landmark Patent for Multi-Element Doped Hard Carbon Composites, Accelerating Sodium-Ion Battery Commercialization

DOVER, USA, May 08, 2026 (GLOBE NEWSWIRE) — E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced the successful patent grant and registration for its proprietary invention: “A Phosphorus-Silver-Silicon Co-Doped Hard Carbon Composite Material and Its Preparation Method” (Patent No: CN2023105784527).

The authorization of this patent marks a pivotal step in the industrialization of E-Power’s advanced hard carbon composite technologies. This achievement provides a robust foundation for the domestic transformation of research into commercial applications, driving innovation in the frontier of new material science.

Revolutionizing Sodium-Ion Battery Anodes

Hard carbon is currently the preferred anode material for the industrialization of sodium-ion batteries. Due to its low degree of structural order and large interlayer spacing, hard carbon effectively overcomes the inherent inability of traditional graphite to intercalate sodium ions.

While common composites involve pitch/resin co-carbonization or integration with conductive materials, E-Power’s P-Ag-Si/HC (Phosphorus-Silver-Silicon Co-Doped Hard Carbon) represents a high-order technical breakthrough designed to optimize performance:

  • Enhanced Capacity and Stability: By incorporating high-capacity Silicon (Si) and high-conductivity Silver (Ag) into the Hard Carbon (HC) matrix, the material achieves superior specific capacity and long-term cycling stability.
  • Interface Regulation: The addition of Phosphorus (P) facilitates the tuning of the electrochemical interface, effectively managing the volume expansion typical of silicon during sodium storage and addressing the conductivity limitations of standard hard carbon.
  • Operational Advantages: The resulting composite maintains the core benefits of hard carbon, including low cost, high charge-discharge rates, and exceptional performance in low-temperature environments.

Driving the Future of Energy Storage

This patent reinforces E-Power’s strategic focus on diversifying its portfolio within the battery material sector. By mastering multi-element doping and pore-structure regulation, the company is providing a critical solution for the next generation of energy storage systems, particularly as the industry shifts toward cost-effective sodium-ion alternatives.

“This patent is a testament to our commitment to leading-edge material innovation,” said Mr. Haiping Hu, Chairman of E-Power. “The P-Ag-Si/HC technology provides a sophisticated answer to the stability and conductivity challenges in sodium-ion batteries, positioning E-Power as a key player in the commercialization of this vital energy transition technology.”

About E-Power Inc.

E-Power Inc., through its joint venture, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. The Company’s joint venture has completed the construction of a manufacturing facility with a production capacity of 50,000 tons .The plant runs on inexpensive electricity from renewable sources, which helps to make E-Power a low-cost and low–environmental-impact producer of graphite anode material. Mr. Haiping Hu, the founder and CEO of the Company, is a major pioneer for the graphite anode industry in the world starting from 1999. The Company’s management team is also composed of experts with years of experiences and strong track-records of success in the graphite anode industry. For further information, please visit the Company’s website at www.sunrisenewenergy.com.

Forward-looking statement

Certain statements in this press release regarding the Company’s future expectations, plans and prospects constitute forward-looking statements as defined by Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about plans, goals, objectives, strategies, future events, expected results, assumptions and any other factual statements that have not occurred. Any words that refer to “may”, “will”, “want”, “should”, “believe”, “expect”, “expect”, “estimate”, “estimate” or similar non-factual words, shall be regarded as forward-looking statements. Due to various factors, the actual results may differ materially from the historical results or the contents expressed in these forward-looking statements. These factors include, but are not limited to, the company’s strategic objectives, the company’s future plans, market demand and user acceptance of the company’s products or services, technological updates, economic trends, the company’s reputation and brand, the impact of industry competition, relevant policies and regulations, China’s macroeconomic conditions, international market conditions, and other related risks and assumptions. In view of the above and other related reasons, we advise investors not to blindly rely on these forward-looking statements, and we urge investors to visit the SEC’s website to consult the company’s relevant documents for other factors that may affect the company’s future operating results. The company is under no obligation to make public amendments to changes in these forward-looking statements due to specific events or reasons unless required by law.

For more information, please contact:

The Company: IR Department

Email: [email protected]

Phone: +1 4084890472



Lamar Advertising to appear at the J.P. Morgan 2026 Global Technology, Media and Communications Conference

BATON ROUGE, La., May 08, 2026 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a question-and-answer session at the J.P. Morgan 2026 Global Technology, Media and Communications Conference on Monday, May 18, 2026 at approximately 3:30 pm EST.

The session will be carried live via audio webcast at the Company’s website, www.lamar.com, and will be archived for 30 days.

About Lamar Advertising Company

Founded in 1902, Lamar Advertising Company (Nasdaq: LAMR) is one of the largest outdoor advertising companies in North America, with over 359,000 displays across the United States and Canada. Lamar offers advertisers a variety of billboard, interstate logo, transit and airport advertising formats, helping both local businesses and national brands reach broad audiences every day. In addition to its more traditional out-of- home inventory, Lamar is proud to offer its customers the largest network of digital billboards in the United States with over 5,600 displays.

Company Contact:

Buster Kantrow
(225) 926-1000
[email protected]



Top Renters Insurance Provider Lemonade Announces Launch of Renters Insurance in New Hampshire

Affordable Renters Insurance in New Hampshire: Lemonade Launches Fast, Digital Coverage Starting at $5/Month

New York City, NY, May 08, 2026 (GLOBE NEWSWIRE) — Lemonade (NYSE: LMND), the tech-first insurance company, has announced the launch of its renters insurance product in New Hampshire. This expansion brings Lemonade’s digital, customizable coverage to renters across the state, further strengthening the company’s presence in the United States.

Lemonade Renters is designed to cover the belongings renters cherish while delivering a superior customer experience. Policies start from $5 per month and are built to be flexible, allowing customers to select coverage amounts and deductibles that fit their lifestyle and budget. Based on the latest industry and Lemonade data, across the U.S., Lemonade Renters is 30 percent more affordable than the typical renters policy.

New Hampshire renters can get a quote, purchase a policy, make changes, and file a claim directly through the Lemonade app. The company’s seamless digital experience enables customers to receive a quote in minutes and manage their coverage on their own terms. Approximately 40 percent of claims are handled instantly, helping customers recover quickly after covered events.

“New Hampshire represents an important step in our continued U.S. growth,” said a spokesperson for Lemonade. “Renters deserve insurance that is fast, easy to understand, and designed around their needs. We are proud to bring our digital-first experience to customers across the state.”

Lemonade’s renters insurance includes coverage for personal property against theft and certain types of damage, personal liability coverage for accidental injury or property damage, medical payments to others, and loss of use coverage if a home becomes unlivable due to a covered loss. Coverage limits and deductibles may vary by state.

Customers may also access savings by bundling policies, installing protective devices, or choosing to pay annually instead of monthly. Lemonade partners with more than 3 million active customers and has earned recognition from organizations including Forbes, CNBC, and U.S. News and World Report for its renters insurance offering.

With the addition of New Hampshire, Lemonade continues to expand its availability, reaching the majority of the U.S. population.

For more information or to get a quote, visit www.lemonade.com.

Frequently Asked Questions about Renters Insurance in New Hampshire

What is the best renters insurance in New Hampshire?

The best renters insurance in New Hampshire combines affordability, strong coverage options, and an easy claims experience. Many renters look for digital-first providers that simplify the process from quote to claim. Top options like Lemonade offer customizable policies and fast, app-based service that stands out in the market.

How much does renters insurance cost in New Hampshire?

Renters insurance in New Hampshire is typically very affordable, with many policies starting around $10–$20 per month depending on coverage levels and location. Leading providers like Lemonade offer policies starting as low as $5 per month, making coverage accessible for most renters. Pricing varies based on factors like deductible, coverage limits, and add-ons.

What does renters insurance cover in New Hampshire?

Renters insurance generally covers personal belongings against theft and certain types of damage, as well as liability protection and additional living expenses if your home becomes uninhabitable. Coverage details can vary by provider and policy. Companies like Lemonade include flexible coverage options that allow renters to tailor protection to their needs.

Is renters insurance required in New Hampshire?

Renters insurance is not required by law in New Hampshire, but many landlords require tenants to carry a policy as part of the lease agreement. Even when it’s optional, it provides valuable protection against unexpected events like theft, fire, or liability claims. Providers like Lemonade make it easy to get covered quickly, often in just a few minutes.

How do I get renters insurance in New Hampshire?

Getting renters insurance in New Hampshire is simple and can often be completed entirely online or through a mobile app. Renters can compare coverage options, choose deductibles, and purchase a policy within minutes. Digital insurers like Lemonade allow customers to manage everything—from quotes to claims—without paperwork or agent visits.

About Lemonade

Lemonade’s mission is to become the most loved insurance company in the world. As a customer-centric tech company, we created an insurance experience across Renters, Home, Pet, Car, and Life that is smart, instant, and delightful. Our team of 1,200+ Lemonade Makers make it possible for over 3M customers throughout the US, UK and Europe to get coverage instantly, with nearly half of claims paid in a matter of seconds. Powered by AI and social impact, Lemonade is a purpose-built, technology-first insurance carrier. A Certified B-Corp, our commitment to social impact is embedded in every aspect of the company, and our Giveback program, which donates a percentage of leftover premiums to nonprofits selected by our community, has donated over $10M to organizations in need.

Press Inquiries

Lemonade Comms
paul.staats [at] lemonade.com



Genie Energy to Report First Quarter 2026 Results 

Annual meeting of Genie stockholders will be held June 10, 2026

NEWARK, NJ, May 08, 2026 (GLOBE NEWSWIRE) — Genie Energy Ltd., (NYSE: GNE), a leading retail energy and renewable energy solutions provider, will announce financial and operational results for the first quarter 2026 on Thursday, May 14, 2026.

Genie Energy will announce its results through an earnings release issued over a wire service and posted in the “Investors” section of the Genie Energy website (https://genie.com/investors/quarterly-earnings/) at 7:30 AM Eastern. The release also will be filed in a current report (Form 8-K) with the SEC.

At 8:30 AM Eastern, Genie Energy’s management will host a conference call to discuss financial and operational results, business outlook, and strategy. The call will begin with management’s remarks followed by Q&A with investors.

To participate in the conference call, dial 1-888-506-0062 (toll-free from the US) or 1-973-528-0011 (international) and provide the following participant access code: 359213.

Approximately three hours after the call, a call replay will be accessible by dialing 1-877-481-4010 (toll-free from the US) or 1-919-882-2331 (international) and providing the replay passcode: 53980. The replay will remain available through Thursday, May 28, 2026. In addition, a recording of the call will be available for playback through the Genie Energy website

The date of Genie Energy’s Annual Meeting of Stockholders has been changed from June 3, 2026 to June 10, 2026 at 2:30 p.m. at Genie Energy’s headquarters (520 Broad Street, 4th Floor, Newark, New Jersey 07102).

In this press release, all statements that are not purely about historical facts, including, but not limited to, those in which we use the words “believe,” “anticipate,” “expect,” “plan,” “intend,” “estimate, “target” and similar expressions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment of what may happen in the future, actual results may differ materially from the results expressed or implied by these statements due to numerous important factors, including, but not limited to, those described in our most recent report on SEC Form 10-K (under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”), which may be revised or supplemented in subsequent reports on SEC Forms 10-Q and 8-K. We are under no obligation, and expressly disclaim any obligation, to update the forward-looking statements in this press release, whether as a result of new information, future events or otherwise. 

About Genie Energy Ltd.: 

Genie Energy Ltd., (NYSE: GNE) is a leading retail energy and renewable energy solutions provider. The Genie Retail Energy division (GRE) supplies electricity, including electricity from renewable resources, and natural gas to residential and small business customers in the United States. The Genie Renewables division (GREW) holds Genie’s energy brokerage and advisory business, a portfolio of solar generation assets, and early-stage growth initiatives. For more information, visit Genie.com.

Contact: 

Genie Energy Investor Relations
Bill Ulrey
E-mail: [email protected] 

# # # 



Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential violations of the federal securities laws.

On February 27, 2026, Fulgent reported its fourth quarter and full year 2025 financial results. The Company disclosed that full year 2025 revenue was approximately $322.7 million, which fell slightly short of the updated guidance previously provided. Fulgent also reported that fourth quarter revenue declined sequentially.

If you suffered a loss in the Company securities, and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys Andrea Farah at (914) 733-7256 or via email to [email protected] or Vincent R. Cappucci Jr. at (914) 733-7278 or via email at [email protected].

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email: [email protected] 



Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential violations of the federal securities laws.

On March 24, 2026, Culper Research, an investigative research firm, published a report titled “ADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.” The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to “stock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.” This allegedly allowed ADMA Biologics to book revenue and “report[] growth that was never there.” According to Culper Research, had ADMA Biologics not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.

If you suffered a loss of more than $50,000 in ADMA Biologics securities, and wish to participate, or learn more about your eligibility, click here, or contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  [email protected] 

SOURCE: Lowey Dannenberg